Shingles Vaccine May Not Be Cost Effective For 50-Year-Olds (FREE)

By Jenni Whalen Edited by David G. Fairchild, MD, MPH The herpes zoster vaccine does not appear to be cost-effective for adults in their 50s, according to a study from the Annals of Internal Medicine.Researchers collected …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news